tiprankstipranks
Scinai Secures $2M Investment Boost
Company Announcements

Scinai Secures $2M Investment Boost

Scinai Immunotherapeutics (SCNI) has released an update.

Don't Miss our Black Friday Offers:

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, has secured a $2 million investment commitment from its largest shareholder, RK Stone Miami LLC. Under the agreement, Scinai may sell shares to the investor until the end of 2024 at a discounted price, with the flexibility to issue shares based on market prices and a limit on shareholder ownership percentages. The deal, which includes a commitment fee and does not necessitate resale registration, strengthens Scinai’s financial position as it continues to develop immunological therapies and provide CDMO services.

For further insights into SCNI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics Reports Financial Turnaround and Growth
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics Gains Shareholder Confidence
TipRanks Auto-Generated NewsdeskScinai Immunotherapeutics to Hold Annual Shareholder Meeting
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App